Premium
Malignant melanoma in organ transplant recipients: incidence, outcomes, and management strategies: a review of literature
Author(s) -
Džambová Martina,
Sečníková Zuzana,
Jiráková Anna,
Jůzlová Kateřina,
Viklický Ondřej,
Hošková Lenka,
Göpfertovà Dana,
Hercogová Jana
Publication year - 2015
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.12276
Subject(s) - medicine , immunosuppression , melanoma , incidence (geometry) , organ transplantation , skin cancer , dermatology , cancer , intensive care medicine , oncology , transplantation , cancer research , physics , optics
Malignant melanoma is considered to be an immunogenic tumor, which is expected to change its behaviour in the field of immunosuppression. Although the incidence of melanoma in organ transplant recipients is increased to a smaller degree than in non‐melanoma skin cancer, its potential morbidity and mortality has to be considered in the posttransplant care. The aim of this review is to investigate the relationship between melanoma and immunosuppression and to discuss management strategies for different melanoma scenarios in pre‐transplant as well as posttransplant period.